ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023 04:00 ET
|
AKAMPION
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area), Switzerland –...
BioMed X and AbbVie Extend Research Collaboration in the US
January 16, 2023 13:00 ET
|
BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
December 06, 2022 07:30 ET
|
BiondVax Pharmaceuticals Ltd.
Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
Multiple Sclerosis Therapeutics Market Size Worth $39.22 Bn by 2027 – The Insight Partners
November 09, 2022 09:12 ET
|
The Insight Partners
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new research study titled "Multiple Sclerosis Therapeutics Market Size, Share, Growth and Forecast to 2027 – COVID-19...
Lyophilized Injectable Drugs Market to hit USD 740 Billion by 2030, says Global Market Insights Inc.
October 11, 2022 06:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report by Global...
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Amro Albanna, CEO of Aditxt, Inc.
August 02, 2022 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
Ultra-large Volume Wearable Injectors Market to Surpass Valuation of US$ 6.6 Bn by 2031: TMR Study
June 09, 2022 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 09, 2022 (GLOBE NEWSWIRE) -- The demand analysis of ultra-large volume wearable injectors reiterates the growing trend of subcutaneous routes of...
Monoclonal Antibodies Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
May 12, 2022 05:00 ET
|
Graphical Research
Pune, India, May 12, 2022 (GLOBE NEWSWIRE) -- The global monoclonal antibodies market size is predicted to witness remarkable growth during the forecast period, due to the rising incidence of...
Throne Biotechnologies Launches Equity Crowdfunding to Support Phase 2 Clinical Trials in Type 1 Diabetes and Alopecia Areata
February 28, 2022 09:00 ET
|
Throne Biotechnologies Inc
PARAMUS, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies, one of the global-leading biotech companies aiming to find a cure for type 1 diabetes, announced the launch of their...
Antibody Therapy Market Revenue to hit $445 Billion by 2028, Says Global Market Insights Inc.
February 22, 2022 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global Market...